ANIK Q2 2018 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M-8.7% YoY

Gross Profit

$22M73.3% margin

Operating Income

$11M36.8% margin

Net Income

$10M33.0% margin

EPS (Diluted)

$0.68

QoQ Revenue Growth

+43.7%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$265M

Total Liabilities

$19M

Stockholders' Equity

$247M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$33M	-8.7%
Gross Profit	$22M	$27M	-17.5%
Operating Income	$11M	$18M	-36.6%
Net Income	$10M	$11M	-11.2%

Revenue Segments

Product

$31M50%

Orthobiologics

$26M43%

Manufactured Product, Other

$2M4%

Surgical

$1M2%

Dermal

$623,0001%

Geographic Segments

UNITED STATES

$25M88%

Europe

$3M12%